Number of items: 5.
Article
Rastogi, N., Baker, S., Man, S., Uger, R., Wong, M., Coles, Steven 
ORCID: https://orcid.org/0000-0002-1109-6971, Hodges, M., Gilkes, A., Knapper, S., Darley, R. and Tonks, A.
(2021)
Use of an anti-CD200 blocking antibody improves immune
responses to AML in vitro and in vivo.
British Journal of Haematology, 193 (1).
pp. 155-159.
ISSN 1365-2141
Coles, Steven ORCID: https://orcid.org/0000-0002-1109-6971, Gilmour, M.N., Reed, R., Knapper, S., Burnett, A.K., Man, S., Tonks, A. and Darley, R.L.
(2015)
The Immunosuppressive Ligands PD-L1 and CD200 are Linked in AML T-cell Immunosuppression: Identification of a New Immunotherapeutic Synapse.
Leukemia, 29 (9).
pp. 1952-1954.
ISSN Print: 0887-6924 Online: 1476-5551
Walsby, E.J., Coles, Steven ORCID: https://orcid.org/0000-0002-1109-6971, Knapper, S. and Burnett, A.K.
(2011)
The Topoisomerase II Inhibitor Voreloxin Causes Cell Cycle Arrest and Apoptosis in Myeloid Leukemia Cells and Acts in Synergy with Cytarabine.
Haematologica, 96 (3).
pp. 393-399.
ISSN Print: 0390-6078 Online: 1592-8721
Conference or Workshop Item
Coles, Steven ORCID: https://orcid.org/0000-0002-1109-6971, Gilmour, M.N., Reid, R., Knapper, S., Burnett, A.K., Man, S., Tonks, A. and Darley, R.L.
(2014)
CD200 and PD1-L1 in AML Are Associated with Expanded PD-1+ Late Differentiated CD8+ T Cells and a Decreased CD4:CD8 Ratio: a New Link Between Distinct Immunosuppressive Pathways.
In: 56th American Society of Hematology Annual Meeting and Exposition, 6th - 9th December 2014, San Francisco.
(Unpublished)
Walsby, E.J., Coles, Steven ORCID: https://orcid.org/0000-0002-1109-6971, Knapper, S., Pepper, C. and Burnett, A.K.
(2009)
Topoisomerase II Inhibitor Voreloxin Causes Cell Cycle Arrest and Apoptosis in Acute Myeloid Leukaemia Cells and Acts in Synergy with Cytarabine.
In: 51st American Society of Hematology (ASH) Annual Meeting and Exposition, 5th - 8th December 2009, New Orleans, LA, USA.
(Unpublished)
This list was generated on Tue Apr 23 05:26:19 2024 UTC.
